Search

everythinglearnresearchcommunity

for

Search:↓

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

New treatments for male hypogonadism are effective and should be personalized.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Men's hair loss is not linked to their sex hormone levels, except for lower DHEAS in those with hair loss.

Longer TA repeats in the SRD5A2 gene may increase acne risk in Chinese people.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Doctors used a special blood sampling technique to diagnose a woman's rare ovarian tumor that was producing male hormones.

PCOS has many symptoms, with high androgen levels being the most common.

The document explains how male reproductive hormones work and affect the body.

A postmenopausal woman's virilization was caused by a rare ovarian tumor that was hard to detect but was successfully treated with surgery.

Some supplements and hormones can increase hair loss by raising DHT levels.

Topical finasteride reduces hair loss and promotes hair growth in men and women.

Spironolactone improved symptoms in women with hormonal imbalances and had few side effects.

Hormonal imbalances are important in the development of male pattern baldness.

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

The new rodent model successfully mimics non-lean human PCOS symptoms.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Serum triglyceride levels are not linked to prostate cancer risk.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.